University spin-out achieves $150 million exit
Thiakis, which specialises in the treatment of obesity and diabetes, has been sold to US-based Wyeth Pharmaecuticals for up to $150 million.
News
Thiakis, which specialises in the treatment of obesity and diabetes, has been sold to US-based Wyeth Pharmaecuticals for up to $150 million.
News
News
Partner content
Accounting and Finance Software
Accounting and Finance Software